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Summary
Retromer is a protein assembly that plays a central role in
orchestrating export of transmembrane-spanning cargo pro-
teins from endosomes into retrieval pathways destined for
the Golgi apparatus and the plasmamembrane [1]. Recently,
a specific mutation in the retromer component VPS35,
VPS35(D620N), has linked retromer dysfunction to familial
autosomal dominant and sporadic Parkinson disease [2, 3].
However, the effect of this mutation on retromer function re-
mains poorly characterized. Here we established that in cells
expressing VPS35(D620N) there is a perturbation in endo-
some-to-TGN transport but not endosome-to-plasma mem-
brane recycling, which we confirm in patient cells harboring
the VPS35(D620N) mutation. Through comparative stable
isotope labeling by amino acids in cell culture (SILAC)-based
analysis of wild-type VPS35 versus the VPS35(D620N)
mutant interactomes, we establish that the major defect of
the D620Nmutation lies in the association to the actin-nucle-
atingWiskott-Aldrich syndrome andSCARhomolog (WASH)
complex. Moreover, using isothermal calorimetry, we estab-
lish that the primary defect of the VPS35(D620N) mutant is
a 2.2 6 0.5-fold decrease in affinity for the WASH complex
component FAM21. These data define the primary mo-
lecular defect in retromer assembly that arises from the
VPS35(D620N) mutation and, by revealing functional effects
on retromer-mediated endosome-to-TGN transport, provide
new insight into retromer deregulation in Parkinson disease.*Correspondence: pete.cullen@bristol.ac.uk
This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).Results and Discussion
Endosome-to-TGN Transport of CI-MPR Is Impaired in
VPS35(D620N)-Expressing Cells
We sought to investigate the effect of the VPS35(D620N)muta-
tion on trafficking of two known retromer cargos, the endo-
some-to-TGN transport of the cation-independent mannose
6-phosphate receptor (CI-MPR) [4–7], and the endosome-to-
plasma membrane transport of the glucose transporter
GLUT1 [8]. At steady state, GLUT1 is localized at the plasma
membrane from where it undergoes continuous rounds of
endocytosis and PDZ ligand-dependent endosome-to-plasma
membrane recycling [9], the latter being mediated by the
SNX27-retromer [8]. In the absence of retromer, GLUT1 accu-
mulates in the lysosome and is degraded [8]. To establish
whether retromer-mediated endosome-to-plasma membrane
transport was affected by the VPS35(D620N)mutation, we per-
formed a quantitative analysis of GLUT1 surface abundance,
lysosomal localization, and kinetics of lysosomal-mediated
degradation [8]. In HeLa or RPE1 cells, the depletion of endo-
genous VPS35 by siRNA-mediated suppression followed
by re-expression of either wild-type GFP-VPS35 or GFP-
VPS35(D620N) produced cell lines where the GFP-tagged
VPS35 transgenes were expressed at near to endogenous
levels (Figure 1C). In these cells, expression of GFP-VPS35
or GFP-VPS35(D620N) efficiently rescued the lysosomal mis-
sorting of GLUT1 observed upon VPS35 suppression (Figures
1A and 1B) (see Figure S1A available online for split channels
and Figure S1B for a larger field of view). Furthermore, while
the knockdown of VPS35 in RPE1 cells led to a pronounced
decrease of GLUT1 surface abundance, re-expression of
wild-type or mutant VPS35 rescued GLUT1 surface abun-
dance (Figures 1A and 1C). Finally, an analysis of GLUT1
degradation kinetics in the RPE1 cells revealed that the post-
translational stability of GLUT1 was not affected by the
VPS35(D620N) mutation (Figures 1Di–1Diii): the degradation
of transferrin receptor was also monitored as a negative
control and as expected its degradation rate was also unaf-
fected by the VPS35(D620N) mutation. Overall, these data
establish that the VPS35(D620N) mutation does not impair ret-
romer-mediated endosome-to-plasmamembrane transport of
GLUT1.
Next, we examined the endosome-to-TGN transport of the
CI-MPR. After delivery to endosomes, CI-MPR dissociates
from its ligand and is recognized by the retromer complex
and retrieved to the TGN for further rounds of ligand binding
and transport [4–7]. In the absence of retromer, the efficiency
of CI-MPR retrieval is perturbed and an increase in endosomal
localization of CI-MPR is observed [4–7]. At steady state in our
RPE1 cell line, CI-MPR was predominantly localized to the
TGN (Figure 1Ei). Suppression of VPS35 led to an increase in
the amount of CI-MPR on dispersed puncta and a decrease
in the Pearson’s correlation between CI-MPR and TGN46 (Fig-
ures 1Ei and 1F). This dispersal and decrease in Pearson’s
correlation was partially rescued by re-expressing GFP-
VPS35 but not GFP-VPS35(D620N) (Figures 1Ei and 1F). The
punctate CI-MPR staining in the VPS35(D620N)-expressing
Figure 1. The VPS35(D620N) Mutation Impairs Endosome-to-TGN Transport of CI-MPR
(A) GFP-VPS35(D620N) expression rescues the lysosomal accumulation of GLUT1 caused by VPS35 suppression. HeLa cells were transduced with lenti-
viruses encoding for RNAi-resistant GFP-VPS35 or GFP-VPS35(D620N) and transfected with siRNA-targeting endogenous VPS35 or a nontargeting siRNA.
Cells were fixed and stained for VPS35, LAMP1, and GLUT1. Scale bar, 10 mm.
(B) The Pearson’s correlation between GLUT1 and Lamp1, in the conditions outlined in (A), quantified from three independent experiments. Approximately
45 cells were analyzed per experiment (*p < 0.01; one-way ANOVA followed by post hoc Tukey test; error bars, SEM).
(C) GFP-VPS35(D620N) expression rescues the loss of GLUT1 from the cell surface caused by VPS35 suppression. The surface abundance of GLUT1 in the
indicated stable RPE1 cells was determined by quantitative immunoblotting.
(Di–Diii) GLUT1 and TfnR degradation kinetics are unaffected by the VPS35(D620N) mutation. The surface of GFP-VPS35 andGFP-VPS35(D620N) cells were
randomly biotinylated. Biotinylated proteins were captured from cell lysates with streptavidin beads at indicated time points after biotinylation and sub-
jected to quantitative immunoblotting on an Odyssey scanner. The plots represent the mean of nine independent experiments (error bars, SEM).
(Ei, Eii, and F) Steady-state localization of endogenousCI-MPR is perturbed in GFP-VPS35(D620N) RPE1 cells. RPE1 cells suppressed for VPS35 expression
and rescued through stable expression of GFP-VPS35 or GFP-VPS35(D620N) were fixed and stained for endogenous CI-MPR (red) and TGN46 (blue). Scale
bar, 10 mm.
(F) The Pearson’s correlation between CI-MPR and TGN46 from three independent experiments (approximately 45 cells were analyzed per experiment) is
shown (*p < 0.01; one-way ANOVA followed by post hoc Tukey test; error bars, SEM).
(G) The percentage of overlap between VPS35 or VPS35(D620N) and CI-MPR in the cell periphery (entire cell area excluding the TGN region) is shown in bar
graph format. Approximately 20 cells from three independent experiments were analyzed (*p < 0.05; unpaired t test; error bars, SD).
(H) Fibroblasts from a healthy donor and a patient harboring the VPS35(D620N) mutation were fixed and stained for endogenous CI-MPR and TGN46.
The Pearson’s correlation between CIMPR and TGN46 from three independent experiments (approximately 35 cells were analyzed per experiment) is shown
(*p < 0.05; unpaired t test; error bars, SEM).
(I) Patient-derived VPS35(D620N) fibroblasts suppressed for endogenous VPS35 and re-expressing wild-type GFP-VPS35 were fixed and stained for endo-
genous CI-MPR and TGN46. Scale bar, 10 mm.
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1671cells was positive for VPS35 (Figure 1Eii), and there was an
increase in the overlap between CI-MPR and VPS35 in the
GFP-VPS35(D620N) cells when compared to GFP-VPS35-
expressing cells (Figure 1G), consistent with a defect in
endosome-to-TGN transport and a corresponding CI-MPR
dispersal. To extend this, we also examined the steady-state
distribution of CI-MPR in fibroblasts obtained from a healthy
donor and from a patient harboring the VPS35(D620N) muta-
tion. Again an increased dispersal of CI-MPR was observed(Figures 1H and 1I). This dispersal was not due to a fragmented
Golgi as both TGN46 and GRASP65 distribution appeared
normal in VPS35(D620N) fibroblasts (Figure S1C). The CI-MPR
dispersal observed in the VPS35(D620N) fibroblasts could be
rescued by suppression of endogenous VPS35 and re-expres-
sion of wild-type GFP-VPS35 (Figure 1I), suggesting that the
differences in CI-MPR distribution are not due to variability
between cell lines isolated from different patients. These
data confirm and extend recent findings of an impairment in
Figure 2. The D620N Mutation in VPS35 Results in a Decrease in Association with the WASH Complex
(A and B) Endosomal localization of VPS35 is not perturbed by the VPS35(D620N) substitution. GFP-VPS35- and GFP-VPS35(D620N)-expressing cells were
fixed and stained for SNX1, EEA1, and LAMP1 (A). The percentage of overlap and Pearson’s correlation are shown in bar graph format (15 fields of view
[approximately 150 cells] from three independent experiments were analyzed; error bars, SEM) (B). Scale bar, 10 mm.
(C and D) Fibroblasts from a healthy donor and a patient harboring the VPS35(D620N) mutation were fixed and stained for endogenous SNX1, EEA1, and
VPS35 (D). The percentage overlap and Pearson’s correlation are shown in bar graph format (approximately 40 cells from three independent experiments
were analyzed; error bars, SEM) (C). Scale bar 10 mm.
(E) GFP-VPS35(D620N) immunoprecipitates WASH complex components to a lesser extent than wild-type VPS35. SILAC-based comparative proteomic
analysis of GFP-trap-precipitated GFP versus GFP-VPS35 and GFP-VPS35(D620N). The GFP-VPS35, GFP-VPS35(D620N), and GFP stable RPE1 cell lines
were grown in normal (GFP), medium-isotope-labeled (VPS35) medium, and heavy-isotope-labeled (VPS35(D620N)) medium, followed by lysis and precip-
itation with GFP-trap beads. Precipitates were pooled, separated by SDS-PAGE, and subjected to gel walking LC–MS/MS analysis on an Orbitrap mass
spectrometer. The SILAC ratio is the fold-enrichment of proteins in GFP-VPS35(D620N) precipitates over GFP-VPS35. Quantitative fluorescent-based
immunoblot analysis of precipitates from the stable RPE1 cell lines broadly confirmed and correlated with the SILAC data.
(F) The immunoprecipitates were repeated three times and the mean fluorescent intensity of selected interactors in the GFP-VPS35(D620N) immunoprecip-
itate compared to the corresponding intensity in the GFP-VPS35 immunoprecipitate are shown (error bars, SEM).
(G and H) Endosomal localization of FAM21 is not perturbed by the VPS35(D620N) substitution. GFP-VPS35- and GFP-VPS35(D620N)-expressing cells were
fixed and stained for FAM21 (G). The Pearson’s correlation and overlap coefficient are shown in bar graph format (40 cells) from three independent exper-
iments were analyzed (error bars, SEM) (H).
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rying the VPS35(D620N) mutation [10, 11].
The VPS35(D620N) Mutant Does Not Perturb the Formation
of theRetromerHeterotrimer or the EndosomeLocalization
of VPS35
To determine the molecular basis of the perturbed endosome-
to-TGNtraffickingobservedwith theVPS35(D620N)mutant,we
first sought to determine whether the VPS35(D620N) mutation
affected formation of the VPS26-VPS29-VPS35 heterotrimer
or its endosomal localization. Like GFP-VPS35, GFP-
VPS35(D620N) localized predominantly to a sorting nexin-1(SNX1) positive early-to-late transitional endosomal compart-
ment (Figures 2A and 2B). In agreement with this, VPS35
showed normal distribution and appearance of the retromer-
decorated endosomal compartment in the fibroblast cells
derived from patient samples as well as comparable colocali-
zationwith SNX1 and the early endocyticmarker EEA1 (Figures
2C and 2D). Immunoisolation followed by western blotting also
established that VPS35(D620N) retained the ability to form a
heterotrimeric complex with VPS29 and VPS26A (Figure 2E).
These data establish that the molecular defect associated
with the VPS35(D620N) mutation lies outside of heterotrimeric
retromer assembly and retromer’s endosome association.
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VPS35(D620N) Mutant
Retromer scaffolds the assembly of a number of accessory
proteins that aid its role in endosomal sorting [1]. To identify
the effect of the VPS35(D620N) mutant on the assembly of
these accessory proteins, we performed an unbiased quanti-
tative analysis of the VPS35 and VPS35(D620N) interactomes.
In a triple SILAC setup, RPE1 cell lines stably expressing GFP,
GFP-VPS35 or GFP-VPS35(D620N) were grown in light (GFP),
medium heavy (GFP-VPS35) and heavy (GFP-VPS35(D620N))
SILACmedia until full steady-state labeling was ensured. Cells
were then subjected to lysis, GFP trap immunoisolation and
pooling of the samples for SDS-PAGE, and subsequent quan-
tification by LC-MS/MS after in-gel tryptic digestion. Known
VPS35-interacting partners VPS26A and VPS26B, VPS29,
TBC1D5 [12], SNX27 [8], and all components of the actin-
polymerizing Wiskott-Aldrich syndrome and SCAR homolog
(WASH) complex [12–17] were enriched in the wild-type
GFP-VPS35 immunoisolation (Tables S1 and S2). In addition,
a number of previously unidentified interactors including
VARP, SDCCAG3, and ANKRD50 were identified, the func-
tional relevance of which will be described elsewhere.
While there is comparative enrichment of VPS29, VPS26A,
and VPS26B between wild-type and VPS35(D620N) (left side
of Figure 2E; Tables S1 and S2), there was a clear decrease in
the enrichment of all components of theWASH complex within
the VPS35(D620N) interactome (Figure 2E; Tables S1 and S2).
In addition, there was a decrease in enrichment of the known
retromer interactor RME-8 [18, 19] and two of the newly identi-
fied interactors SDCCAG3 and ANKRD50 (Figure 2E; Tables S1
andS2). In contrast, therewasno loss inbinding toother known
retromer interactors such as TBC1D5 [20] and SNX27 [8] and
the newly identified interactor VARP [12] (Figure 2E; Tables
S1 and S2). Validating the mass spectrometric quantification,
fluorescence-based quantitative western analysis confirmed
the decrease in binding of these proteins to the VPS35(D620N)
mutant (Figures 2E and 2F). Given the loss of binding to the
WASH complex observed in the GFP-VPS35(D620N) cells, we
sought to investigate whether the membrane association of
the WASH complex is impaired in the VPS35(D620N)-express-
ing cells. We saw no obvious impairment of FAM21 endosomal
localization or a decrease in Pearson’s correlation between
GFP-VPS35(D620N) and FAM21 (Figures 2Gand 2H). However,
we cannot rule out that the loss of binding to the WASH
complex alters turnover of the WASH complex on the endo-
some or affects the endosomal subdomain organization of
the retromer and WASH complexes.
The Binding of ANKRD50, SDCCAG3, and RME-8 to
Retromer Is Mediated through the WASH Complex
To identify the primary defect in the VPS35(D620N) mutant, we
performed a series of GFP-VPS35 immunoisolations from cells
treated with RNAi’s targeting FAM21—the component of the
WASH complex that directly binds to VPS35 [16], ANKRD50,
SDCCAG3, and RME-8. Suppression of FAM21 resulted in a
loss in the enrichment of ANKRD50, SDCCAG3, and RME-8
in GFP-VPS35 immunoisolates (Figures 3A–3C), establishing
that these proteins interact indirectly with retromer through
the WASH complex. Suppression of ANKRD50, SDCCAG3,
and RME-8 did not affect the binding of FAM21 to VPS35 (Fig-
ures 3A–3C).
To correlate these data with the previously described endo-
some association of SDCCAG3 and RME-8 [21, 22], we
analyzed parallel experiments using immunofluorescence.Confirming published data, suppression of VPS35 led to the
dissociation of FAM21 from endosomes (Figures 3D and 3E)
[15, 16]. Consistent with the biochemical analysis, the endo-
some association of SDCCAG3 required the presence of
both retromer and FAM21 (Figures 3D and 3E). In contrast,
the endosome association of RME-8 was only partially depen-
dent on retromer and FAM21 (Figures 3D and 3E), which is
consistent with the known binding of RME-8 to other endo-
some-associated proteins including SNX1 [18]. Together,
these data establish that the association of ANKRD50,
SDCCAG3, and RME-8 to retromer is mediated through bind-
ing to the WASH complex, and for SDCCAG3 this is necessary
for targeting to retromer-labeled endosomes. Moreover, they
provide evidence that the major defect of the VPS35(D620N)
mutant lies with the association to the WASH complex.
The VPS35(D620N) mutation has been suggested to inhibit
the neuroprotective effect of VPS35 [23], so we sought
to investigate whether suppression of VPS35, FAM21,
SDCCAG3, RME-8, or ANKRD50 enhanced the toxicity and
increased cell death observed in the neuroblastoma cell line
SH-SY5Y upon exposure to MPP+, which interferes with com-
plex I of the electron transport chain inmitochondrion, causing
cell death. However, no increase in cell death upon suppres-
sion of any of these components was observed (Figure S2)
when the cells were incubated in 500 mM of MPP+ for 48 hr.
This is in line with a previous study that found no effect of
VPS35 suppression on cell survival when SH-SY5Y cells
were challenged with MPP+ [23]. However, the absence of
an effect could also be due to insufficient suppression of these
components in SH-SY5Y cells.
VPS35(D620N) Impairs Its Interaction with FAM21 In Vitro
Previous studies have suggested that the interaction between
the retromer and FAM21 is mediated by the VPS35 and VPS29
(but not VPS26) subunits of the retromer heterotrimer and
multiple LFa motifs from the C terminus of FAM21 [15, 16,
24]. FAM21 contains 21 such LFa motifs with varied affinities
to the VPS35/VPS29 complex. The two most C-terminal
ones, R20 and R21, bind to the VPS35/VPS29 complex with
the highest affinity, and deletion of R20-21 abolished endoso-
mal localization of FAM21 in cells [16]. Thus, to evaluate the
effect of the VPS35(D620N) substitution, we examinedwhether
this mutation affects the affinity of the VPS35/VPS29 complex
to the R20-21 fragment by using isothermal titration calorim-
etry (ITC).
The recombinant VPS35/VPS29 complex was purified by
colysing individually expressing bacterial cells as described
previously [16]. The VPS35(D620N) substitution did not
affect complex formation with VPS29, further confirming our
biochemical and proteomic analysis (Figures 2E and 2F). The
ITC experiments for each VPS35/VPS29 complex were
repeated three times with two independently prepared protein
samples and slightly different injection protocols. Raw data
were pooled and subjected to global fitting using the software
package SEDPHAT. Similar to our previous studies, VPS35/
VPS29 bound R20-21 with a stoichiometry of 1:2 [16]. The
affinity of VPS35(D620N)/VPS29 to R20-21 (Kd = 4.6 6
0.7 mM) was significantly lower (by 2.2 6 0.5-fold) than that of
the wild-type VPS35/VPS29 (Kd = 2.4 6 0.6 mM) (Figures 4A
and 4B). These results establish that the VPS35(D620N) substi-
tution impairs its interaction with FAM21.
In addition to R20-21, we also attempted to measure the
affinity for a larger fragment of FAM21, R15-21. Although the
ITC thermograms were qualitatively consistent with a reduced
Figure 3. The WASH Complex Is Required for the Association of RME8, SDCCAG3, and ANKRD50 with VPS35
(A, B, and C) GFP-VPS35-expressing RPE1 cells were transfected with nontargeting siRNA or siRNA against FAM21, RME-8, SDCCAG3, or ANKRD50 prior
to GFP-trap immunoprecipitation of GFP-VPS35 and immunoblotting with antibodies raised against FAM21, SDCCAG3, RME-8, ANKRD50, Tubulin, and
GFP. Suppression of FAM21 resulted in a loss of SDCCAG3 (A), RME-8 (B), and ANKRD50 (C) from VPS35 immunoprecipitates. Suppression of RME-8,
SDCCAG3, or ANKRD50 did not affect the ability of VPS35 to immunoprecipitate FAM21.
(D) FAM21 and retromer are required for the endosomal localization of SDCCAG3. HeLa cells were transfected with nontargeting siRNA or siRNA against
VPS35, FAM21, RME-8, or SDCCAG3 prior to imaging of the endogenous localization of each protein. Scale bar, 10 mm.
(E) The number of puncta per cell above a set threshold intensity, from three independent experiments (30 cells per experiment), for the indicated proteins
was quantified using Volocity (*p < 0.01; one-way ANOVA followed by post hoc Tukey test; error bars, SD).
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ment contains seven LFa motifs potentially interacting with
VPS35/VPS29, it was not possible to quantitatively fit and
interpret these data (data not shown).
In summary, stemming from an unbiased quantitative prote-
omic analysis, we have identified that at themolecular level the
primary effect of the Parkinson disease-linked VPS35(D620N)
mutation is a decrease in the affinity for FAM21 and as a con-
sequence a reduced association with the WASH complex and
its associated proteins, including RME-8, and the newly iden-
tified retromer-associated proteins SDCCAG3 and ANKRD50.
While not perturbing retromer-mediated endosome-to-plasma
membrane recycling of GLUT1, this partial loss of FAM21
binding and the WASH complex-associated proteins does
lead to a decrease in the efficiency of endosomes-to-TGN
retrieval of the CI-MPR. While the primary defect of the
VPS35(D620N) mutation is a decrease in affinity for the
WASH complex, it is important to stress that the observed
phenotypes maybe arise from a reduced activity of RME8,
SDCCAG3, or ANKRD50 or a combination of these and
FAM21. This is consistent with the current view that WASH-mediated actin polymerization is required for the organization
and maturation of retromer sorting domains on early-to-late
transition endosomes [16]. Precisely why the decrease in
coupling to the WASH complex, and associated proteins,
leads to a selective retromer effect on endosome-to-TGN
over endosome-to-plasma membrane transport is unclear
and will require further investigation. With evidence linking
mutations in the WASH complex component strumpellin to
hereditary spastic paraplegia [25], and the recent description
of an RME-8(N855S) mutation that segregates with late-onset
Parkinson disease [26], the data presented here establish that
the association and function relationship between retromer
and WASH complexes will be an important area in defining
the role of defective endosomal sorting in these neurodegen-
erative diseases.
During the final stages of reviewing our manuscript
Zavodszky and colleagues, using a candidate approach,
published work consistent with a defect in WASH binding to
the VPS35(D620N) mutant [27]. Our detailed biochemical anal-
ysis extends their findings and, importantly, through our unbi-
ased global analysis, highlights that the corresponding loss of
Figure 4. VPS35(D620N) Has Reduced Affinity for the FAM21 Tail
(A) Isothermal titration calorimetry of FAM21R20-21 titrated into the VPS35/VPS29 complex. Top, middle, and bottom panels are from representative exper-
iments showing raw, integrated heat, and fitting residuals, respectively. The black curve in the middle panel represents a fit of the integrated data. Left:
VPS35WT/VPS29. Right: VPS35D620N/VPS29.
(B) Quantification of the dissociation constant (Kd) determined from three independent ITC experiments for each protein complex as shown in (A). All values
are presented as mean6 SD, derived from software package SEDPHAT for a global fitting. Student’s t test was used to determine the difference of the two
sets of data.
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1675RME-8, SDCCAG3, and/or ANKRD50 may also contribute to
the defect in retromer function in Parkinson disease. As
such, the role of these newly identified retromer interactors
offers a potentially exciting avenue of research into the causes
of this neurodegenerative disease.
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